Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Pancreatic surgery is complicated and risky, especially for pancreatic cancer. It's been noticed that having these surgeries done at specialized centers can lead to better outcomes and survival rates. However, factors like patient selection and hospital conditions also play an important role. Some studies show that more surgeries done at a hospital might not always mean better results, as the type of patients and procedures can vary. To understand this better, the present study compared outcomes and patient characteristics between high-volume pancreatic centers and others.
The study utilized German nationwide administrative data (diagnosis-related group statistics) spanning from 2010 to 2018. Persons who underwent pancreatic resections during this period were included, with exclusions for certain criteria like underage and type of procedure. Various factors including patient demographics, diagnoses, procedures, and comorbidities were analyzed to assess in-hospital mortality rates. High-volume pancreatic centers (HVPCs) were identified as those performing at least 50 procedures annually. Statistical analyses included comparing crude and adjusted mortality rates and assessing patient characteristics between HVPCs and non-HVPCs. Models were adjusted for multiple variables, and methods like the Cochran-Armitage trend test and mixed models were employed. Additionally, the study investigated how differences in patient characteristics between HVPCs and non-HVPCs affected mortality rates.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients treated in high-volume pancreatic centers | Patients treated at a hospital performing at least 50 pancreatic resection procedures annually during 2010 to 2018 |
| |
| Patients treated in low-volume pancreatic centers | Patients not treated at a hospital performing at least 50 pancreatic resection procedures annually during 2010 to 2018 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Persons with pancreatic resection in a hospital with at least 50 pancreatic resections annually (observational), | Other | Persons that have undergone a pancreatic resection at a hospital with at least 50 pancreatic resections annually (observational) |
| Measure | Description | Time Frame |
|---|---|---|
| In-hospital mortality | Death | 30 days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
The study population encompasses all patients that underwent any pancreatic resection procedure in any German hospital (full survey of the German population).
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Rene Mantke, MD, PhD | Head of Surgery at University Hospital Brandenburg an der Havel | Study Director |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40134472 | Derived | Mantke R, Seliger B, Ogino S, Buchler MW, Hunger R. Not Only Caseload but Also Patient Selection Is Predictive of Mortality After Pancreatic Resection. Ann Surg Open. 2024 Dec 30;6(1):e536. doi: 10.1097/AS9.0000000000000536. eCollection 2025 Mar. |
Not provided
Not provided
Individual participant data is not available for data sharing.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Persons with pancreatic resection in a hospital not performing at least 50 pancreatic resections annually (observational), | Other | Persons that have undergone a pancreatic resection at a hospital with not at least 50 pancreatic resections annually (observational) |
|
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| ID | Term |
|---|---|
| D004066 | Digestive System Diseases |
Not provided
Not provided